Clinical Research and Regulatory Support Core
临床研究和监管支持核心
基本信息
- 批准号:10474450
- 负责人:
- 金额:$ 32.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateAgeAttentionBehavior TherapyBiometryBurn injuryCOVID-19 pandemicCase Report FormChildChronic DiseaseClinicClinicalClinical InvestigatorClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesCommunitiesCommunity DevelopmentsCommunity OutreachComplementDataData AnalysesDatabasesDevelopmentElderlyEnsureEthicsFacultyFailureFeasibility StudiesFilipinoFood SupplementsFundingGoalsHawaiiHealthHealth ProfessionalHuman ResourcesIndigenousInfrastructureInpatientsInstitutionInstitutional Review BoardsKnowledgeLaboratory TechniciansLeadMedicalMedical DeviceMedical centerMentorsNative HawaiianNursing ResearchOutpatientsPacific IslanderParticipantPatient RightsPerinatalPersonsPharmacologic SubstancePhysiciansPilot ProjectsPlayProceduresProcessReduce health disparitiesRegulatory AffairsResearchResearch DesignResearch PersonnelResourcesRoleSafetyScienceScientistServicesTechnologyTimeTranslational ResearchTrustUnderserved PopulationUniversitiesVulnerable PopulationsWomanWorkbaseclinical research sitecommunity engagementcommunity settingdesignepidemiology studyhealth disparityhuman subjectimprovedinnovationmedical schoolsmedically underserved populationoperationoutreachpatient safetyprogramspsychologicsoundtranslational scientistwasting
项目摘要
The proposed Clinical Research and Regulatory Support (CRRS) Core will play a vital role in enhancing the
development of a robust clinical and translational (CTR) infrastructure for the Center for Pacific Innovations,
Knowledge, and Opportunities (PIKO). The CRRS Core will provide Junior Investigators (JI), and Established
Investigators (EI) transitioning to CTR across the CTR continuum, with the necessary clinical research expertise,
resources, and facilities to conduct CTR aimed at improving the health of Indigenous Pacific People (IPP),
defined as Native Hawaiians, Other Pacific Islanders, and Filipinos, and other medically underserved and
vulnerable groups. The CRRS Core will also assist JI/EI in navigating the daunting process of ensuring that their
proposed research is ethical and addresses all human subject and regulatory concerns. The CRRS Core will
promote harmonization of institutional review board procedures throughout community and partner institutions,
participate in mentoring activities organized by the Professional Development (PD) Core, collaborate with the
Biostatistics, Epidemiology, and Research Design (BERD) Core in developing case report forms and inputting
data into the study database, and work with the Community Engagement and Outreach (CEO) Core to share
information with health care professionals and community leaders. This Core’s Specific Aims are:
Specific Aim 1: Mentor CTR investigators on the practical aspects of conducting high-quality CTR
by assisting JI/EI with study feasibility and implementation issues; facilitating linkage to medical resources and
advocate for transdisciplinary and team-science opportunities; providing regulatory mentoring support for CTR
implementation; participating in PIKO-sponsored professional development activities.
Specific Aim 2: Enable direct access to critical CTR implementation resources and facilities by
providing CTR personnel resources (research nurse/associate and processing laboratory technician services);
providing access to clinic facilities; enabling access to an independent Data Safety Monitoring Board and Ethics
Board resources; advancing CTR technology and outreach to support T2–T5 clinical research.
The CRRS Core will provide services at three clinical sites – John A. Burns School of Medicine (JABSOM),
Queen’s Medical Center (QMC), and Kapiolani Medical Center for Women and Children (KMCWC). As CRRS
Core Director, Cecilia M. Shikuma, MD, supported by Associate Core Directors Todd Seto, MD, and Bliss
Kaneshiro, MD, will oversee the Core operations at JABSOM, QMC and KMCWC, respectively. Venkataraman
Balaraman, MD, will oversee the ethics and regulatory services. The innovation of combining regulatory and
ethics resources with CTR implementation services within a single core will allow the CRRS Core to offer
integrated and personalized services to JI/EI engaging in CTR.
拟议的临床研究和监管支持(CRRS)核心将在加强
为太平洋创新中心开发强大的临床和转化(CTR)基础设施,
知识和机会(PIKO)。CRRS核心将提供初级研究者(JI),
研究者(EI)在CTR连续体中过渡到CTR,具有必要的临床研究专业知识,
资源和设施,以开展旨在改善太平洋土著人民健康的社区康复,
定义为夏威夷土著人,其他太平洋岛民和菲律宾人,以及其他医疗服务不足的人,
弱势群体CRRS核心还将协助联合执行/环境影响评估在确保其
拟议的研究符合伦理,并涉及所有人类受试者和监管问题。CRRS核心将
促进整个社区和伙伴机构的机构审查委员会程序的统一,
参加由专业发展(PD)核心组织的辅导活动,与
生物统计学,流行病学和研究设计(BERD)开发病例报告表和输入的核心
数据输入研究数据库,并与社区参与和外联(CEO)核心合作,
与卫生保健专业人员和社区领导人的信息。该核心的具体目标是:
具体目标1:指导CTR研究者进行高质量CTR的实践方面
协助联合执行/环境倡议处理研究可行性和执行问题;促进与医疗资源的联系,
倡导跨学科和团队科学机会;为CTR提供监管指导支持
执行;参加PIKO主办的专业发展活动。
具体目标2:通过以下方式直接获取关键CTR实施资源和设施:
提供CTR人力资源(研究护士/助理和处理实验室技术人员服务);
提供诊所设施的使用权;允许使用独立的数据安全监测委员会和伦理委员会
董事会资源;推进CTR技术和推广,以支持T2-T5临床研究。
CRRS核心将在三个临床站点提供服务- John A.伯恩斯医学院(JABSOM),
皇后医疗中心(QMC)和Kapiolani妇女和儿童医疗中心(KMCWC)。作为CRRS
核心总监,Cecilia M. Shikuma,医学博士,由副核心董事托德濑户,医学博士和布利斯提供支持
Kaneshiro博士将分别监督JABSOM、QMC和KMCWC的核心业务。Venkataraman
医学博士巴拉拉曼将监督道德和监管服务。将监管和
道德资源与CTR实施服务在一个单一的核心将允许CRRS核心提供
为参与CTR的联合执行/环境影响评估提供综合和个性化的服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cecilia M. Shikuma其他文献
S100B and its association with HIV-associated neurocognitive disorders
- DOI:
10.1007/s13365-019-00773-8 - 发表时间:
2019-07-05 - 期刊:
- 影响因子:1.900
- 作者:
Nath Limpruttidham;Brooks I. Mitchell;Kalpana J. Kallianpur;Beau K. Nakamoto;Scott A. Souza;Bruce Shiramizu;Lishomwa C. Ndhlovu;Dominic C. Chow;Cecilia M. Shikuma - 通讯作者:
Cecilia M. Shikuma
Cecilia M. Shikuma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cecilia M. Shikuma', 18)}}的其他基金
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
HIV 和全球药物治疗:周围神经病变并发症和机制
- 批准号:
8112457 - 财政年份:2008
- 资助金额:
$ 32.55万 - 项目类别:
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms
HIV 和全球药物治疗:周围神经病变并发症和机制
- 批准号:
8133664 - 财政年份:2008
- 资助金额:
$ 32.55万 - 项目类别:
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
氧化应激和炎症在艾滋病毒心血管风险中的作用
- 批准号:
7691231 - 财政年份:2008
- 资助金额:
$ 32.55万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 32.55万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 32.55万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 32.55万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 32.55万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 32.55万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 32.55万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 32.55万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 32.55万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 32.55万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 32.55万 - 项目类别: